About Shengtai Pharmaceutical

Shengtai Pharmaceutical, Inc., through its direct and indirect subsidiaries, manufactures and distributes glucose and starch as pharmaceutical raw materials, other starch products, and other glucose products, such as corn meals, food and beverage glucose and dextrin in the People’s Republic of China (PRC). Products The company manufactures products in three categories: raw materials for pharmaceutical and medicinal companies or purposes, raw materials for the food and beverage industries, and other products. Raw materials for pharmaceutical and medicinal companies or purposes: The company’s major pharmaceutical and medical grade products include Dextrose Monohydrate (DMH), Dextrose Anhydrous (DA), Dextrin, and Pharmaceutical Grade Cornstarch. Raw Materials for the Food and Beverage and Processing Industries: Its major raw materials for the food and beverage and processing industries: Rough Glucose for Other Processing Purposes, Dextrose Monohydrate Oral, and Food and Beverage Grade Cornstarch. Other Products: The company’s other products include Fibers, Corn Embryo, Protein Powder, Mother Liquid, Dextrin, and Abamectin ointment. Sales and Marketing As of June 30, 2012, all the provinces in the mainland PRC (except Tibet) have been covered by its domestic sales network. The company’s products are mainly exported to Asia and southeast Asia. Suppliers The company’s major supplier includes Fujian Sha County Qingshan Chemical Carbon Corporation. Customers The company’s principal customers are: healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies located in the PRC. Its principal customers are hospitals and pharmaceutical companies, such as K.F.P; H.K.W; Weifang Century-light Industry Co Ltd; Shandong Kaiqiang Biological Chemical Co.,Ltd; Qingdao Shizhan Science and Technology Co. Ltd; Qingdao Chenyu Biochemical Technology Co.,Ltd; Shandong Samsung Corn Industry Science and Technology Co.,Ltd; Qingdao Longli International Trading Co Ltd; Toyota Commerce(Shanghai) Co.,Ltd; and Shandong Xinxinhai Grain and Oil Industry Co.,Ltd. Intellectual Property The company’s trademark includes ‘Heng De Bao’. Regulations The company is subject to the laws governing the Good Practice in the Manufacturing and Quality Control of Drugs (as amended in 1998) as promulgated by the PRC State Food and Drug Administration on March 18, 1999. The company is also subject to business license and approval regulations that are required for all corporations in the PRC. The company has obtained Certificates of Good Manufacturing Practices for Pharmaceutical Products, ‘GMP Certificates,’ issued by the PRC State Food and Drug Administration. The GMP Certificates certify that the company has complied with the requirements of Chinese Current Good Manufacturing Practices for Pharmaceutical Products in the manufacture of Dextrose Monohydrate oral glucose, Dextrose Monohydrate glucose, and Anhydrous glucose and the GMP Certificate is valid through November 10, 2013. Additionally, the company has obtained Drug Registration Certificates for glucose and glucose pro oral from the State Food and Drug Administration in accordance with the PRC Medical Products Governance Law and its implementing regulations. Competition The company’s competitors include Shangdong Xiangrui Pharmaceutical Co., Ltd; Hebei Shengxue Glucose Co., Ltd; Shandong Xi Wang Pharmaceutical Co., Ltd; QinHuangDao Lihua Starch Co., Ltd; Shandong Luzhou Biotechnology Co., Ltd; Jiliang Group; Shandong Dongxiao Biotechnology Co., Ltd; and Henan Feitian Starch glucose Co. Ltd. History Shengtai Pharmaceutical, Inc. was incorporated in 2004 in the state of Delaware.